Skip to main content
Fig. 3 | BMC Biotechnology

Fig. 3

From: Myogenic differentiation of primary myoblasts and mesenchymal stromal cells under serum-free conditions on PCL-collagen I-nanoscaffolds

Fig. 3

Gene expression of myogenic markers in Mb, BMSC/Mb, and ADSC/Mb after serum-free myogenic differentiation. Expressions are demonstrated in x-fold difference compared with Mb, BMSC/Mb, ADSC/Mb stimulated with standard myogenic differentiation medium (ctrl. = control = 1) using the 2-ΔΔCt-method. Markers are presented as mean ± standard deviation. In Mb, serum-free differentiation led to a downregulation of ACTN2 (alpha actinin skeletal muscle 2). Statistical differences were tested with one-way ANOVA and Bonferroni‘s correction for multiple comparisons (n = 3). Levels of significance were * p ≤ 0.05, ** p ≤ 0.01

Back to article page